Osteoporosis is a major health care burden in Europe which results in 4.3 million fragility fractures and health care costs in excess of €56 billion annually.

Presenting impactful data for ...

In achieving its enrolment target in November 2021, an important milestone has been reached by the Phase III PLX-PAD study. 

HIPGEN - Cell Therapy for Improving Patient Mobility after Hip Fracture ...

Vascular calcification, low bone mass and fragility fractures are all frequent age-dependent disorders. Recent clinical and experimental data suggest that vascular calcification and bone loss could share pathophysiological mechanisms. 

A ...

‘The Hipgen Trial - Cell Therapy for Improving Patient Mobility after Hip Fracture Arthroplasty’, is among the many topical symposia scheduled at the upcoming virtual World Congress on ...

Patients with advanced chronic kidney disease (CKD) typically suffer from impaired bone quality and quantity, with a non-vertebral fracture risk which is 4-to 6-fold higher than the fracture risk of ...

Leer esta noticia en español 

A new international guidance on the clinical application of high-resolution peripheral computed tomography (HR-pQCT) offers an important overview of current clinical applications in adults and ...

Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant haematological diseases. 

To address this ...

A new study by the IFCC‑IOF Committee for Bone Metabolism shows large within- and between-assay variation for ß-CTX measurement; until harmonization is achieved, proposes measuring ß-CTX by the same assay ...

A global survey of healthcare providers by the International Osteoporosis Foundation (IOF), the National Osteoporosis Foundation (NOF) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and ...

Vertebral fractures often remain undetected, despite their significance as risk factors for future fractures. The routine use of vertebral fracture assessment (VFA) in fracture liaison services would help physicians detect ...

Bone turnover markers (BTMs) in blood and urine are useful tools in monitoring osteoporosis treatment effects and may be useful for improving patient adherence. 

In 2011, a Joint Committee on ...

A detailed analysis of the burden of osteoporosis in eight Eurasian countries has found that osteoporosis is a significant and growing health problem in the region that will escalate in ...